Phibro Animal Health Corp (PAHC) Updates FY17 Earnings Guidance

Phibro Animal Health Corp (NASDAQ:PAHC) issued an update on its FY17 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of $1.44-1.47 for the period, compared to the Thomson Reuters consensus estimate of $1.43. The company issued revenue guidance of $760-765 million, compared to the consensus revenue estimate of $757.20 million.

Several equities research analysts recently commented on the company. Zacks Investment Research raised Phibro Animal Health Corp from a hold rating to a buy rating and set a $38.00 price objective on the stock in a research report on Thursday, May 11th. Piper Jaffray Companies raised their target price on Phibro Animal Health Corp from $32.00 to $34.00 and gave the stock an overweight rating in a research report on Wednesday, February 8th. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the stock. The stock currently has an average rating of Hold and an average target price of $29.17.

Phibro Animal Health Corp (NASDAQ:PAHC) traded down 0.73% on Friday, hitting $34.10. The stock had a trading volume of 18,142 shares. Phibro Animal Health Corp has a 52-week low of $17.96 and a 52-week high of $35.15. The company has a 50 day moving average price of $29.68 and a 200-day moving average price of $28.49. The company has a market cap of $1.35 billion, a price-to-earnings ratio of 21.18 and a beta of 1.34.

Phibro Animal Health Corp (NASDAQ:PAHC) last posted its earnings results on Monday, May 8th. The company reported $0.37 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.37. Phibro Animal Health Corp had a return on equity of 63.70% and a net margin of 7.90%. The business had revenue of $190 million for the quarter, compared to analysts’ expectations of $185.90 million. During the same quarter in the previous year, the firm earned $0.38 earnings per share. The business’s revenue was up 3.5% compared to the same quarter last year. On average, equities research analysts predict that Phibro Animal Health Corp will post $1.45 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 22nd. Stockholders of record on Wednesday, May 31st will be given a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.16%. The ex-dividend date is Friday, May 26th. Phibro Animal Health Corp’s dividend payout ratio (DPR) is currently 26.85%.

In other news, insider Jack Bendheim sold 1,400 shares of Phibro Animal Health Corp stock in a transaction dated Wednesday, May 10th. The stock was sold at an average price of $34.04, for a total transaction of $47,656.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Gerald K. Carlson sold 63,338 shares of Phibro Animal Health Corp stock in a transaction dated Thursday, May 11th. The stock was sold at an average price of $33.31, for a total value of $2,109,788.78. Following the sale, the director now owns 50 shares in the company, valued at approximately $1,665.50. The disclosure for this sale can be found here. Insiders have sold 187,296 shares of company stock worth $5,866,634 in the last quarter. Insiders own 48.09% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Phibro Animal Health Corp (PAHC) Updates FY17 Earnings Guidance” was originally posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this news story on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The legal version of this news story can be viewed at https://www.chaffeybreeze.com/2017/05/19/phibro-animal-health-corp-pahc-updates-fy17-earnings-guidance-updated.html.

Several hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in shares of Phibro Animal Health Corp by 8.2% in the first quarter. Vanguard Group Inc. now owns 1,729,406 shares of the company’s stock valued at $48,597,000 after buying an additional 130,935 shares during the period. Geode Capital Management LLC boosted its position in shares of Phibro Animal Health Corp by 9.9% in the first quarter. Geode Capital Management LLC now owns 162,869 shares of the company’s stock valued at $4,576,000 after buying an additional 14,655 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Phibro Animal Health Corp by 12.3% in the first quarter. Dimensional Fund Advisors LP now owns 396,007 shares of the company’s stock valued at $11,128,000 after buying an additional 43,260 shares during the period. Morgan Stanley boosted its position in shares of Phibro Animal Health Corp by 1.7% in the first quarter. Morgan Stanley now owns 172,773 shares of the company’s stock valued at $4,855,000 after buying an additional 2,868 shares during the period. Finally, Renaissance Technologies LLC boosted its position in shares of Phibro Animal Health Corp by 269.8% in the first quarter. Renaissance Technologies LLC now owns 51,400 shares of the company’s stock valued at $1,444,000 after buying an additional 37,500 shares during the period. Institutional investors and hedge funds own 47.35% of the company’s stock.

Phibro Animal Health Corp Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

5 Day Chart for NASDAQ:PAHC

Receive News & Ratings for Phibro Animal Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corp and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply